{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:40:17Z","timestamp":1793817617468,"version":"4.6.1"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2023-00285353"],"award-info":[{"award-number":["RS-2023-00285353"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research Foundation of Kore","award":["RS-2024-00458567"],"award-info":[{"award-number":["RS-2024-00458567"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Angiogenesis, the process of new blood vessel formation, is a fundamental physiological process implicated in several pathological disorders. The vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) are crucial for angiogenesis and vasculogenesis. Among them, the tyrosine kinase receptor VEGFR-2 is primarily expressed in endothelial cells (ECs). These cells regulate various physiological responses, including differentiation, cell proliferation, migration, and survival, by binding to VEGF mitogens. Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) is a key regulator of this process, making it a prime target for therapeutic intervention. Several drugs targeting VEGFR-2 have been approved and are currently utilized to halt the pathological axis of VEGF-VEGFR. This review will focus on the recent developments in the molecular structure and function of VEGFR-2, the molecular mechanism of VEGFR-2 activation, and its downstream signaling pathway. It will also discuss therapies and experimental drugs approved to inhibit the function of VEGFR-2 and the resistance mechanism.<\/jats:p>","DOI":"10.1007\/s12272-025-01545-1","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T14:34:06Z","timestamp":1746714846000},"page":"404-425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Targeting vascular endothelial growth receptor-2 (VEGFR-2): structural biology, functional insights, and therapeutic resistance"],"prefix":"10.1007","volume":"48","author":[{"given":"Fahad Hassan","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Seok","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Young","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Seo","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Hong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minkyoung","family":"Ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0620-6937","authenticated-orcid":false,"given":"Heon-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"1545_CR1","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1002\/cncr.26540","volume":"118","author":"SE Abdullah","year":"2012","unstructured":"Abdullah SE, Perez-Soler R (2012) Mechanisms of resistance to vascular endothelial growth factor blockade. Cancer 118:3455\u20133467. https:\/\/doi.org\/10.1002\/cncr.26540","journal-title":"Cancer"},{"key":"1545_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12079-016-0352-8","volume":"10","author":"CS Abhinand","year":"2016","unstructured":"Abhinand CS, Raju R, Soumya SJ, Arya PS, Sudhakaran PR (2016) VEGF-A\/VEGFR2 signaling network in endothelial cells relevant to angiogenesis. J Cell Commun Signal 10:347\u2013354. https:\/\/doi.org\/10.1007\/s12079-016-0352-8","journal-title":"J Cell Commun Signal"},{"key":"1545_CR3","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1172\/JCI18549","volume":"112","author":"A Abramsson","year":"2003","unstructured":"Abramsson A, Lindblom P, Betsholtz C (2003) Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest 112:1142\u20131151. https:\/\/doi.org\/10.1172\/JCI18549","journal-title":"J Clin Invest"},{"key":"1545_CR4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1002\/jcb.30344","volume":"123","author":"A Ahmad","year":"2022","unstructured":"Ahmad A, Nawaz MI (2022) Molecular mechanism of VEGF and its role in pathological angiogenesis. J Cell Biochem 123:1938\u20131965. https:\/\/doi.org\/10.1002\/jcb.30344","journal-title":"J Cell Biochem"},{"key":"1545_CR5","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/nature04480","volume":"438","author":"K Alitalo","year":"2005","unstructured":"Alitalo K, Tammela T, Petrova TV (2005) Lymphangiogenesis in development and human disease. Nature 438:946\u2013953. https:\/\/doi.org\/10.1038\/nature04480","journal-title":"Nature"},{"key":"1545_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00018-022-04251-z","volume":"79","author":"A Arora","year":"2022","unstructured":"Arora A, Kivela AM, Wang L, Minkeviciene R, Taskinen JH, Zhang B, Koponen A, Sun J, Shirane M, Zhou Y, Hotulainen P, Raiborg C, Olkkonen VM (2022) Protrudin regulates FAK activation, endothelial cell migration and angiogenesis. Cell Mol Life Sci 79:220. https:\/\/doi.org\/10.1007\/s00018-022-04251-z","journal-title":"Cell Mol Life Sci"},{"key":"1545_CR7","doi-asserted-by":"publisher","first-page":"7448","DOI":"10.1038\/s41598-025-90624-w","volume":"15","author":"CH Baek","year":"2025","unstructured":"Baek CH, Kim H, Moon SY, Lee EK, Yang WS (2025) AKT activation triggers Rab14-mediated ADAM10 translocation to the cell surface in human aortic endothelial cells. Sci Rep 15:7448. https:\/\/doi.org\/10.1038\/s41598-025-90624-w","journal-title":"Sci Rep"},{"key":"1545_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.canlet.2010.03.010","volume":"296","author":"HS Ban","year":"2010","unstructured":"Ban HS, Uno M, Nakamura H (2010) Suppression of hypoxia-induced HIF-1alpha accumulation by VEGFR inhibitors: different profiles of AAL993 versus SU5416 and KRN633. Cancer Lett 296:17\u201326. https:\/\/doi.org\/10.1016\/j.canlet.2010.03.010","journal-title":"Cancer Lett"},{"key":"1545_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ccr.2006.11.021","volume":"11","author":"TT Batchelor","year":"2007","unstructured":"Batchelor TT, Sorensen AG, Di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK (2007) AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11:83\u201395. https:\/\/doi.org\/10.1016\/j.ccr.2006.11.021","journal-title":"Cancer Cell"},{"key":"1545_CR10","doi-asserted-by":"publisher","first-page":"10660","DOI":"10.1074\/jbc.M609048200","volume":"282","author":"MG Blanes","year":"2007","unstructured":"Blanes MG, Oubaha M, Rautureau Y, Gratton JP (2007) Phosphorylation of tyrosine 801 of vascular endothelial growth factor receptor-2 is necessary for Akt-dependent endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells. J Biol Chem 282:10660\u201310669. https:\/\/doi.org\/10.1074\/jbc.M609048200","journal-title":"J Biol Chem"},{"key":"1545_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30543","volume":"125","author":"GS Bose","year":"2024","unstructured":"Bose GS, Kalakoti G, Kulkarni AP, Mittal S (2024) AP-1\/C-FOS and AP-1\/FRA2 differentially regulate early and late adipogenic differentiation of mesenchymal stem cells. J Cell Biochem 125:e30543. https:\/\/doi.org\/10.1002\/jcb.30543","journal-title":"J Cell Biochem"},{"key":"1545_CR12","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1158\/1078-0432.CCR-11-0699","volume":"18","author":"AN Brooks","year":"2012","unstructured":"Brooks AN, Kilgour E, Smith PD (2012) Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer. Clin Cancer Res 18:1855\u20131862. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0699","journal-title":"Clin Cancer Res"},{"key":"1545_CR13","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/dmrr.415","volume":"19","author":"RB Caldwell","year":"2003","unstructured":"Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Caldwell RW (2003) Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 19:442\u2013455. https:\/\/doi.org\/10.1002\/dmrr.415","journal-title":"Diabetes Metab Res Rev"},{"key":"1545_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2174\/1389450054021981","volume":"6","author":"RB Caldwell","year":"2005","unstructured":"Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Liou GI, Caldwell RW (2005) Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets 6:511\u2013524. https:\/\/doi.org\/10.2174\/1389450054021981","journal-title":"Curr Drug Targets"},{"key":"1545_CR15","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","volume":"296","author":"LC Cantley","year":"2002","unstructured":"Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655\u20131657. https:\/\/doi.org\/10.1126\/science.296.5573.1655","journal-title":"Science"},{"key":"1545_CR16","doi-asserted-by":"publisher","first-page":"13117","DOI":"10.1074\/jbc.RA119.008643","volume":"294","author":"KB Chandler","year":"2019","unstructured":"Chandler KB, Leon DR, Kuang J, Meyer RD, Rahimi N, Costello CE (2019) N-Glycosylation regulates ligand-dependent activation and signaling of vascular endothelial growth factor receptor 2 (VEGFR2). J Biol Chem 294:13117\u201313130. https:\/\/doi.org\/10.1074\/jbc.RA119.008643","journal-title":"J Biol Chem"},{"key":"1545_CR17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39624","volume":"15","author":"M Chaudhuri","year":"2023","unstructured":"Chaudhuri M, Hassan Y, Bakka Vemana PPS, Bellary Pattanashetty MS, Abdin ZU, Siddiqui HF (2023) Age-related macular degeneration: an exponentially emerging imminent threat of visual impairment and irreversible blindness. Cureus 15:e39624. https:\/\/doi.org\/10.7759\/cureus.39624","journal-title":"Cureus"},{"key":"1545_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115456","volume":"257","author":"Q Chen","year":"2023","unstructured":"Chen Q, Chen Z, Li F, Zha H, He W, Jiang F, Wei J, Xu J, Li R, Cai L, Liu X (2023) Discovery of highly potent and selective VEGFR2 kinase inhibitors for the treatment of rheumatoid arthritis. Eur J Med Chem 257:115456. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115456","journal-title":"Eur J Med Chem"},{"key":"1545_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107173","volume":"203","author":"Q Chen","year":"2024","unstructured":"Chen Q, Xu N, Zhao C, He Y, Kam SHT, Wu X, Huang P, Yang M, Wong CTT, Radis-Baptista G, Tang B, Fan G, Gong G, Lee SM (2024a) A new invertebrate NPY-like polypeptide, ZoaNPY, from the Zoanthus sociatus, as a novel ligand of human NPY Y2 receptor rescues vascular insufficiency via PLC\/PKC and Src- FAK-dependent signaling pathways. Pharmacol Res 203:107173. https:\/\/doi.org\/10.1016\/j.phrs.2024.107173","journal-title":"Pharmacol Res"},{"key":"1545_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-024-01773-9","volume":"9","author":"X Chen","year":"2024","unstructured":"Chen X, Xu H, Chen X, Xu T, Tian Y, Wang D, Guo F, Wang K, Jin G, Li X, Wang R, Li F, Ding Y, Tang J, Fang Y, Zhao J, Liu L, Ma L, Meng L, Hou Z, Zheng R, Liu Y, Guan N, Zhang B, Tong S, Chen S, Li X, Shu Y (2024b) First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study. Signal Transduct Target Ther 9:73. https:\/\/doi.org\/10.1038\/s41392-024-01773-9","journal-title":"Signal Transduct Target Ther"},{"key":"1545_CR21","doi-asserted-by":"publisher","first-page":"1448570","DOI":"10.3389\/fphar.2024.1448570","volume":"15","author":"H Cheng","year":"2024","unstructured":"Cheng H, Men Y, An Y, Yu J, Zhang G, Li J, Wang X, Sun G, Wu Y (2024) Overexpression of endothelial S1pr2 promotes blood-brain barrier disruption via JNK\/c-Jun\/MMP-9 pathway after traumatic brain injury in both in vivo and in vitro models. Front Pharmacol 15:1448570. https:\/\/doi.org\/10.3389\/fphar.2024.1448570","journal-title":"Front Pharmacol"},{"key":"1545_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/eye.2015.217","volume":"30","author":"V Chong","year":"2016","unstructured":"Chong V (2016) Ranibizumab for the treatment of wet AMD: a summary of real-world studies. Eye (Lond) 30:270\u2013286. https:\/\/doi.org\/10.1038\/eye.2015.217","journal-title":"Eye (Lond)"},{"key":"1545_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0311-6","volume":"51","author":"TW Chung","year":"2019","unstructured":"Chung TW, Kim EY, Choi HJ, Han CW, Jang SB, Kim KJ, Jin L, Koh YJ, Ha KT (2019) 6\u2019-Sialylgalactose inhibits vascular endothelial growth factor receptor 2-mediated angiogenesis. Exp Mol Med 51:1\u201313. https:\/\/doi.org\/10.1038\/s12276-019-0311-6","journal-title":"Exp Mol Med"},{"key":"1545_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fcell.2017.00101","volume":"5","author":"V Comunanza","year":"2017","unstructured":"Comunanza V, Bussolino F (2017) Therapy for cancer: strategy of combining anti-angiogenic and target therapies. Front Cell Dev Biol 5:101. https:\/\/doi.org\/10.3389\/fcell.2017.00101","journal-title":"Front Cell Dev Biol"},{"key":"1545_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccr.2008.12.004","volume":"15","author":"Y Crawford","year":"2009","unstructured":"Crawford Y, Kasman I, Yu L, Zhong C, Wu X, Modrusan Z, Kaminker J, Ferrara N (2009) PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 15:21\u201334. https:\/\/doi.org\/10.1016\/j.ccr.2008.12.004","journal-title":"Cancer Cell"},{"key":"1545_CR26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.cell.2014.01.043","volume":"156","author":"DO Croci","year":"2014","unstructured":"Croci DO, Cerliani JP, Dalotto-Moreno T, Mendez-Huergo SP, Mascanfroni ID, Dergan-Dylon S, Toscano MA, Caramelo JJ, Garcia-Vallejo JJ, Ouyang J, Mesri EA, Junttila MR, Bais C, Shipp MA, Salatino M, Rabinovich GA (2014) Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell 156:744\u2013758. https:\/\/doi.org\/10.1016\/j.cell.2014.01.043","journal-title":"Cell"},{"key":"1545_CR27","first-page":"707","volume":"47","author":"R Derynck","year":"1987","unstructured":"Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH (1987) Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 47:707\u201312","journal-title":"Cancer Res"},{"key":"1545_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.bbamcr.2009.09.017","volume":"1803","author":"EI Deryugina","year":"2010","unstructured":"Deryugina EI, Quigley JP (2010) Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions. Biochim Biophys Acta 1803:103\u2013120. https:\/\/doi.org\/10.1016\/j.bbamcr.2009.09.017","journal-title":"Biochim Biophys Acta"},{"key":"1545_CR29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/21224","volume":"399","author":"S Dimmeler","year":"1999","unstructured":"Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601\u2013605. https:\/\/doi.org\/10.1038\/21224","journal-title":"Nature"},{"key":"1545_CR30","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/onc.2014.164","volume":"34","author":"KM Dodd","year":"2015","unstructured":"Dodd KM, Yang J, Shen MH, Sampson JR, Tee AR (2015) mTORC1 drives HIF-1alpha and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1, and STAT3. Oncogene 34:2239\u20132250. https:\/\/doi.org\/10.1038\/onc.2014.164","journal-title":"Oncogene"},{"key":"1545_CR31","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1038\/sj.emboj.7600289","volume":"23","author":"J Dong","year":"2004","unstructured":"Dong J, Grunstein J, Tejada M, Peale F, Frantz G, Liang WC, Bai W, Yu L, Kowalski J, Liang X, Fuh G, Gerber HP, Ferrara N (2004) VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis. EMBO J 23:2800\u20132810. https:\/\/doi.org\/10.1038\/sj.emboj.7600289","journal-title":"EMBO J"},{"key":"1545_CR32","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1210\/en.2008-1207","volume":"150","author":"NC Douglas","year":"2009","unstructured":"Douglas NC, Tang H, Gomez R, Pytowski B, Hicklin DJ, Sauer CM, Kitajewski J, Sauer MV, Zimmermann RC (2009) Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse. Endocrinology 150:3845\u20133854. https:\/\/doi.org\/10.1210\/en.2008-1207","journal-title":"Endocrinology"},{"key":"1545_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.semcdb.2004.01.002","volume":"15","author":"J Downward","year":"2004","unstructured":"Downward J (2004) PI 3-kinase, Akt, and cell survival. Semin Cell Dev Biol 15:177\u2013182. https:\/\/doi.org\/10.1016\/j.semcdb.2004.01.002","journal-title":"Semin Cell Dev Biol"},{"key":"1545_CR34","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1091\/mbc.e07-05-0467","volume":"18","author":"M Duval","year":"2007","unstructured":"Duval M, Le Boeuf F, Huot J, Gratton JP (2007) Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase. Mol Biol Cell 18:4659\u20134668. https:\/\/doi.org\/10.1091\/mbc.e07-05-0467","journal-title":"Mol Biol Cell"},{"key":"1545_CR35","doi-asserted-by":"publisher","first-page":"17069","DOI":"10.1073\/pnas.0708148104","volume":"104","author":"JM Ebos","year":"2007","unstructured":"Ebos JM, Lee CR, Christensen JG, Mutsaers AJ, Kerbel RS (2007) Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy. Proc Natl Acad Sci U S A 104:17069\u201317074. https:\/\/doi.org\/10.1073\/pnas.0708148104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1545_CR36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1161\/CIRCRESAHA.120.316851","volume":"127","author":"G Eelen","year":"2020","unstructured":"Eelen G, Treps L, Li X, Carmeliet P (2020) Basic and Therapeutic Aspects of Angiogenesis Updated. Circ Res 127:310\u2013329. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316851","journal-title":"Circ Res"},{"key":"1545_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000521584","volume":"59","author":"R Eguchi","year":"2022","unstructured":"Eguchi R, Kawabe JI, Wakabayashi I (2022) VEGF-independent angiogenic factors: beyond VEGF\/VEGFR2 signaling. J Vasc Res 59:78\u201389. https:\/\/doi.org\/10.1159\/000521584","journal-title":"J Vasc Res"},{"key":"1545_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","volume":"328","author":"E Fagiani","year":"2013","unstructured":"Fagiani E, Christofori G (2013) Angiopoietins in angiogenesis. Cancer Lett 328:18\u201326. https:\/\/doi.org\/10.1016\/j.canlet.2012.08.018","journal-title":"Cancer Lett"},{"key":"1545_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583687","volume":"11","author":"JV Forrester","year":"2020","unstructured":"Forrester JV, Kuffova L, Delibegovic M (2020) The role of inflammation in diabetic retinopathy. Front Immunol 11:583687. https:\/\/doi.org\/10.3389\/fimmu.2020.583687","journal-title":"Front Immunol"},{"key":"1545_CR40","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","volume":"16","author":"JA Forsythe","year":"1996","unstructured":"Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604\u20134613. https:\/\/doi.org\/10.1128\/MCB.16.9.4604","journal-title":"Mol Cell Biol"},{"key":"1545_CR41","doi-asserted-by":"publisher","first-page":"11197","DOI":"10.1074\/jbc.273.18.11197","volume":"273","author":"G Fuh","year":"1998","unstructured":"Fuh G, Li B, Crowley C, Cunningham B, Wells JA (1998) Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J Biol Chem 273:11197\u201311204. https:\/\/doi.org\/10.1074\/jbc.273.18.11197","journal-title":"J Biol Chem"},{"key":"1545_CR42","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/21218","volume":"399","author":"D Fulton","year":"1999","unstructured":"Fulton D, Gratton JP, Mccabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597\u2013601. https:\/\/doi.org\/10.1038\/21218","journal-title":"Nature"},{"key":"1545_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202204994","volume":"35","author":"H Gao","year":"2023","unstructured":"Gao H, Chen M, Liu Y, Zhang D, Shen J, Ni N, Tang Z, Ju Y, Dai X, Zhuang A, Wang Z, Chen Q, Fan X, Liu Z, Gu P (2023) Injectable anti-inflammatory supramolecular nanofiber hydrogel to promote anti-VEGF therapy in age-related macular degeneration treatment. Adv Mater 35:e2204994. https:\/\/doi.org\/10.1002\/adma.202204994","journal-title":"Adv Mater"},{"key":"1545_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1042\/BST0360203","volume":"36","author":"S Garrido-Urbani","year":"2008","unstructured":"Garrido-Urbani S, Bradfield PF, Lee BP, Imhof BA (2008) Vascular and epithelial junctions: a barrier for leucocyte migration. Biochem Soc Trans 36:203\u2013211. https:\/\/doi.org\/10.1042\/BST0360203","journal-title":"Biochem Soc Trans"},{"key":"1545_CR45","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/ncb1486","volume":"8","author":"J Gavard","year":"2006","unstructured":"Gavard J, Gutkind JS (2006) VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8:1223\u20131234. https:\/\/doi.org\/10.1038\/ncb1486","journal-title":"Nat Cell Biol"},{"key":"1545_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175586","volume":"949","author":"S Ghalehbandi","year":"2023","unstructured":"Ghalehbandi S, Yuzugulen J, Pranjol MZI, Pourgholami MH (2023) The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF. Eur J Pharmacol 949:175586. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175586","journal-title":"Eur J Pharmacol"},{"key":"1545_CR47","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/ATVBAHA.123.320000","volume":"44","author":"H Giri","year":"2024","unstructured":"Giri H, Biswas I, Rezaie AR (2024) Thrombomodulin regulates PTEN\/AKT signaling axis in endothelial cells. Arterioscler Thromb Vasc Biol 44:352\u2013365. https:\/\/doi.org\/10.1161\/ATVBAHA.123.320000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1545_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113837","volume":"43","author":"JL Herrera","year":"2024","unstructured":"Herrera JL, Komatsu M (2024) Akt3 activation by R-Ras in an endothelial cell enforces quiescence and barrier stability of neighboring endothelial cells via Jagged1. Cell Rep 43:113837. https:\/\/doi.org\/10.1016\/j.celrep.2024.113837","journal-title":"Cell Rep"},{"key":"1545_CR49","doi-asserted-by":"publisher","first-page":"8249","DOI":"10.1158\/0008-5472.CAN-04-1567","volume":"64","author":"K Hida","year":"2004","unstructured":"Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, Morton CC, Klagsbrun M (2004) Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res 64:8249\u20138255. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1567","journal-title":"Cancer Res"},{"key":"1545_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s42003-024-07431-8","volume":"8","author":"C Hiepen","year":"2025","unstructured":"Hiepen C, Benamar M, Barrasa-Fano J, Condor M, Ilhan M, Munch J, Hastar N, Kerkhoff Y, Harms GS, Mielke T, Koenig B, Block S, Rocks O, Abdelilah-Seyfried S, Van Oosterwyck H, Knaus P (2025) Endothelial tip-cell position, filopodia formation and biomechanics require BMPR2 expression and signaling. Commun Biol 8:21. https:\/\/doi.org\/10.1038\/s42003-024-07431-8","journal-title":"Commun Biol"},{"key":"1545_CR51","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1038\/s41388-024-03113-1","volume":"43","author":"H Hoffmann","year":"2024","unstructured":"Hoffmann H, Wartenberg M, Vorlova S, Karl-Scholler F, Kallius M, Reinhardt O, Ozturk A, Schuhmair LS, Burkhardt V, Gatzner S, Scheld D, Nandigama R, Zernecke A, Herterich S, Ergun S, Rosenwald A, Henke E (2024) Normalization of Snai1-mediated vessel dysfunction increases drug response in cancer. Oncogene 43:2661\u20132676. https:\/\/doi.org\/10.1038\/s41388-024-03113-1","journal-title":"Oncogene"},{"key":"1545_CR52","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","volume":"19","author":"K Holmes","year":"2007","unstructured":"Holmes K, Roberts OL, Thomas AM, Cross MJ (2007) Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 19:2003\u20132012. https:\/\/doi.org\/10.1016\/j.cellsig.2007.05.013","journal-title":"Cell Signal"},{"key":"1545_CR53","doi-asserted-by":"publisher","first-page":"22267","DOI":"10.1074\/jbc.M312729200","volume":"279","author":"K Holmqvist","year":"2004","unstructured":"Holmqvist K, Cross MJ, Rolny C, Hagerkvist R, Rahimi N, Matsumoto T, Claesson-Welsh L, Welsh M (2004) The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J Biol Chem 279:22267\u201322275. https:\/\/doi.org\/10.1074\/jbc.M312729200","journal-title":"J Biol Chem"},{"key":"1545_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.612802","author":"A Hooglugt","year":"2021","unstructured":"Hooglugt A, Van Der Stoel MM, Boon RA, Huveneers S (2021) Endothelial YAP\/TAZ signaling in angiogenesis and tumor vasculature. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.612802","journal-title":"Front Oncol"},{"key":"1545_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061413","author":"Z Hu","year":"2020","unstructured":"Hu Z, Cano I, Saez-Torres KL, Leblanc ME, Saint-Geniez M, Ng YS, Argueso P, D\u2019amore PA (2020) Elements of the endomucin extracellular domain essential for VEGF-induced VEGFR2 activity. Cells. https:\/\/doi.org\/10.3390\/cells9061413","journal-title":"Cells"},{"key":"1545_CR56","doi-asserted-by":"publisher","first-page":"284","DOI":"10.31138\/mjr.20230801.oo","volume":"34","author":"M Jahid","year":"2023","unstructured":"Jahid M, Khan KU, Rehan Ul H, Ahmed RS (2023) Overview of rheumatoid arthritis and scientific understanding of the disease. Mediterr J Rheumatol 34:284\u2013291. https:\/\/doi.org\/10.31138\/mjr.20230801.oo","journal-title":"Mediterr J Rheumatol"},{"key":"1545_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111850","volume":"131","author":"F Jiang","year":"2024","unstructured":"Jiang F, Wang MQ, Zhang MY, Gu SL, Xie YW, Huang Y, Zhou MY, Li FL, Yang YC, Zhang PP, Liu XS, Li R (2024) CPD-002, a novel VEGFR2 inhibitor, relieves rheumatoid arthritis by reducing angiogenesis through the suppression of the VEGFR2\/PI3K\/AKT signaling pathway. Int Immunopharmacol 131:111850. https:\/\/doi.org\/10.1016\/j.intimp.2024.111850","journal-title":"Int Immunopharmacol"},{"key":"1545_CR58","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/s44161-022-00172-z","volume":"1","author":"Y Jin","year":"2022","unstructured":"Jin Y, Ding Y, Richards M, Kaakinen M, Giese W, Baumann E, Szymborska A, Rosa A, Nordling S, Schimmel L, Akmeric EB, Pena A, Nwadozi E, Jamalpour M, Holstein K, Sainz-Jaspeado M, Bernabeu MO, Welsh M, Gordon E, Franco CA, Vestweber D, Eklund L, Gerhardt H, Claesson-Welsh L (2022) Tyrosine-protein kinase Yes controls endothelial junctional plasticity and barrier integrity by regulating VE-cadherin phosphorylation and endocytosis. Nat Cardiovasc Res 1:1156\u20131173. https:\/\/doi.org\/10.1038\/s44161-022-00172-z","journal-title":"Nat Cardiovasc Res"},{"key":"1545_CR59","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s10637-022-01325-4","volume":"41","author":"Z Kang","year":"2023","unstructured":"Kang Z, Li S, Lin Y, Li Y, Mao Y, Zhang J, Lei T, Wang H, Su Y, Yang Y, Qiu J, Li W (2023) A phase I dose-escalation study of SYHA1813, a VEGFR and CSF1R inhibitor, in patients with recurrent high-grade gliomas or advanced solid tumors. Invest New Drugs 41:296\u2013305. https:\/\/doi.org\/10.1007\/s10637-022-01325-4","journal-title":"Invest New Drugs"},{"key":"1545_CR60","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2174\/1381612829666230420083431","volume":"29","author":"E Karami","year":"2023","unstructured":"Karami E, Azizi P, Behdani M, Kazemi-Lomedasht F (2023) Efficient inhibition of pathologic angiogenesis using combination therapy of anti-Epcam and Anti-VEGFR2 nanobodies. Curr Pharm des 29:1059\u20131066. https:\/\/doi.org\/10.2174\/1381612829666230420083431","journal-title":"Curr Pharm des"},{"key":"1545_CR61","first-page":"5687","volume":"55","author":"O Katoh","year":"1995","unstructured":"Katoh O, Tauchi H, Kawaishi K, Kimura A, Satow Y (1995) Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res 55:5687\u20135692","journal-title":"Cancer Res"},{"key":"1545_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26041076","author":"NEM Kaufman","year":"2021","unstructured":"Kaufman NEM, Dhingra S, Jois SD, Vicente M (2021) Molecular Targeting of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR). Molecules. https:\/\/doi.org\/10.3390\/molecules26041076","journal-title":"Molecules"},{"key":"1545_CR63","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s00262-024-03777-4","volume":"73","author":"NH Kim","year":"2024","unstructured":"Kim NH, Lee J, Kim SH, Kang SH, Bae S, Yu CH, Seo J, Kim HT (2024) ALK5\/VEGFR2 dual inhibitor TU2218 alone or in combination with immune checkpoint inhibitors enhances immune-mediated antitumor effects. Cancer Immunol Immunother 73:190. https:\/\/doi.org\/10.1007\/s00262-024-03777-4","journal-title":"Cancer Immunol Immunother"},{"key":"1545_CR64","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1074\/jbc.M808958200","volume":"284","author":"Ii Knezevic","year":"2009","unstructured":"Knezevic Ii, Predescu SA, Neamu RF, Gorovoy MS, Knezevic NM, Easington C, Malik AB, Predescu DN (2009) Tiam1 and Rac1 are required for platelet-activating factor-induced endothelial junctional disassembly and increase in vascular permeability. J Biol Chem 284:5381\u20135394. https:\/\/doi.org\/10.1074\/jbc.M808958200","journal-title":"J Biol Chem"},{"key":"1545_CR65","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006502","volume":"2","author":"S Koch","year":"2012","unstructured":"Koch S, Claesson-Welsh L (2012) Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med 2:a006502. https:\/\/doi.org\/10.1101\/cshperspect.a006502","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1545_CR66","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1042\/BJ20110301","volume":"437","author":"S Koch","year":"2011","unstructured":"Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437:169\u2013183. https:\/\/doi.org\/10.1042\/BJ20110301","journal-title":"Biochem J"},{"key":"1545_CR67","doi-asserted-by":"publisher","DOI":"10.1172\/JCI155478","author":"EA Korhonen","year":"2022","unstructured":"Korhonen EA, Murtomaki A, Jha SK, Anisimov A, Pink A, Zhang Y, Stritt S, Liaqat I, Stanczuk L, Alderfer L, Sun Z, Kapiainen E, Singh A, Sultan I, Lantta A, Leppanen VM, Eklund L, He Y, Augustin HG, Vaahtomeri K, Saharinen P, Makinen T, Alitalo K (2022) Lymphangiogenesis requires Ang2\/Tie\/PI3K signaling for VEGFR3 cell-surface expression. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI155478","journal-title":"J Clin Invest"},{"key":"1545_CR68","doi-asserted-by":"publisher","first-page":"34009","DOI":"10.1074\/jbc.M603928200","volume":"281","author":"L Lamalice","year":"2006","unstructured":"Lamalice L, Houle F, Huot J (2006) Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2\/p38 activation and endothelial cell migration in response to VEGF. J Biol Chem 281:34009\u201334020. https:\/\/doi.org\/10.1074\/jbc.M603928200","journal-title":"J Biol Chem"},{"key":"1545_CR69","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrneurol.2016.88","volume":"12","author":"C Lange","year":"2016","unstructured":"Lange C, Storkebaum E, De Almodovar CR, Dewerchin M, Carmeliet P (2016) Vascular endothelial growth factor: a neurovascular target in neurological diseases. Nat Rev Neurol 12:439\u2013454. https:\/\/doi.org\/10.1038\/nrneurol.2016.88","journal-title":"Nat Rev Neurol"},{"key":"1545_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105387","author":"THV Le","year":"2021","unstructured":"Le THV, Kwon SM (2021) Vascular endothelial growth factor biology and its potential as a therapeutic target in rheumatic diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22105387","journal-title":"Int J Mol Sci"},{"key":"1545_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellsig.2017.06.012","volume":"38","author":"HJ Lee","year":"2017","unstructured":"Lee HJ, Diaz MF, Ewere A, Olson SD, Cox CS Jr, Wenzel PL (2017) Focal adhesion kinase signaling regulates anti-inflammatory function of bone marrow mesenchymal stromal cells induced by biomechanical force. Cell Signal 38:1\u20139. https:\/\/doi.org\/10.1016\/j.cellsig.2017.06.012","journal-title":"Cell Signal"},{"key":"1545_CR72","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00221-011-2849-y","volume":"214","author":"WL Li","year":"2011","unstructured":"Li WL, Fraser JL, Yu SP, Zhu J, Jiang YJ, Wei L (2011) The role of VEGF\/VEGFR2 signaling in peripheral stimulation-induced cerebral neurovascular regeneration after ischemic stroke in mice. Exp Brain Res 214:503\u2013513. https:\/\/doi.org\/10.1007\/s00221-011-2849-y","journal-title":"Exp Brain Res"},{"key":"1545_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.698532","volume":"9","author":"Y Li","year":"2021","unstructured":"Li Y, He H, Jihu R, Zhou J, Zeng R, Yan H (2021) Novel characterization of myeloid-derived suppressor cells in tumor microenvironment. Front Cell Dev Biol 9:698532. https:\/\/doi.org\/10.3389\/fcell.2021.698532","journal-title":"Front Cell Dev Biol"},{"key":"1545_CR74","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1038\/s41467-023-37671-x","volume":"14","author":"R Li","year":"2023","unstructured":"Li R, Shao J, Jin YJ, Kawase H, Ong YT, Troidl K, Quan Q, Wang L, Bonnavion R, Wietelmann A, Helmbacher F, Potente M, Graumann J, Wettschureck N, Offermanns S (2023) Endothelial FAT1 inhibits angiogenesis by controlling YAP\/TAZ protein degradation via E3 ligase MIB2. Nat Commun 14:1980. https:\/\/doi.org\/10.1038\/s41467-023-37671-x","journal-title":"Nat Commun"},{"key":"1545_CR75","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.2147\/IJN.S444009","volume":"19","author":"Y Li","year":"2024","unstructured":"Li Y, Chen J, Quan X, Chen Y, Han Y, Chen J, Yang L, Xu Y, Shen X, Wang R, Zhao Y (2024a) Extracellular vesicles maintain blood-brain barrier integrity by the suppression of caveolin-1\/CD147\/VEGFR2\/MMP pathway after ischemic stroke. Int J Nanomed 19:1451\u20131467. https:\/\/doi.org\/10.2147\/IJN.S444009","journal-title":"Int J Nanomed"},{"key":"1545_CR76","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13287-024-03832-y","volume":"15","author":"Z Li","year":"2024","unstructured":"Li Z, Wu W, Li Q, Heng X, Zhang W, Zhu Y, Chen L, Chen Z, Shen M, Ma N, Xiao Q, Yan Y (2024b) BCL6B-dependent suppression of ETV2 hampers endothelial cell differentiation. Stem Cell Res Ther 15:226. https:\/\/doi.org\/10.1186\/s13287-024-03832-y","journal-title":"Stem Cell Res Ther"},{"key":"1545_CR77","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13045-022-01310-7","volume":"15","author":"Y Liu","year":"2022","unstructured":"Liu Y, Li Y, Wang Y, Lin C, Zhang D, Chen J, Ouyang L, Wu F, Zhang J, Chen L (2022) Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy. J Hematol Oncol 15:89. https:\/\/doi.org\/10.1186\/s13045-022-01310-7","journal-title":"J Hematol Oncol"},{"key":"1545_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106425","volume":"133","author":"XJ Liu","year":"2023","unstructured":"Liu XJ, Zhao HC, Hou SJ, Zhang HJ, Cheng L, Yuan S, Zhang LR, Song J, Zhang SY, Chen SW (2023) Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy. Bioorg Chem 133:106425. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106425","journal-title":"Bioorg Chem"},{"key":"1545_CR79","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.cellsig.2011.03.003","volume":"23","author":"B Ma","year":"2011","unstructured":"Ma B, Xiang Y, An L (2011) Structural bases of physiological functions and roles of the vacuolar H(+)-ATPase. Cell Signal 23:1244\u20131256. https:\/\/doi.org\/10.1016\/j.cellsig.2011.03.003","journal-title":"Cell Signal"},{"key":"1545_CR80","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jconrel.2023.10.038","volume":"364","author":"CML Machado","year":"2023","unstructured":"Machado CML, Skubal M, Haedicke K, Silva FP, Stater EP, Silva T, Costa ET, Masotti C, Otake AH, Andrade LNS, Junqueira MS, Hsu HT, Das S, Larney BM, Pratt EC, Romin Y, Fan N, Manova-Todorova K, Pomper M, Grimm J (2023) Membrane-derived particles shed by PSMA-positive cells function as pro-angiogenic stimuli in tumors. J Control Release 364:312\u2013325. https:\/\/doi.org\/10.1016\/j.jconrel.2023.10.038","journal-title":"J Control Release"},{"key":"1545_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186454","author":"CD Maida","year":"2020","unstructured":"Maida CD, Norrito RL, Daidone M, Tuttolomondo A, Pinto A (2020) Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21186454","journal-title":"Int J Mol Sci"},{"key":"1545_CR82","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s13402-021-00602-3","volume":"44","author":"J Majidpoor","year":"2021","unstructured":"Majidpoor J, Mortezaee K (2021) Angiogenesis as a hallmark of solid tumors - clinical perspectives. Cell Oncol (Dordr) 44:715\u2013737. https:\/\/doi.org\/10.1007\/s13402-021-00602-3","journal-title":"Cell Oncol (Dordr)"},{"key":"1545_CR83","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.1096\/fj.14-256206","volume":"28","author":"S Manni","year":"2014","unstructured":"Manni S, Kisko K, Schleier T, Missimer J, Ballmer-Hofer K (2014) Functional and structural characterization of the kinase insert and the carboxy terminal domain in VEGF receptor 2 activation. FASEB J 28:4914\u20134923. https:\/\/doi.org\/10.1096\/fj.14-256206","journal-title":"FASEB J"},{"key":"1545_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100251","volume":"3","author":"V Mariotti","year":"2021","unstructured":"Mariotti V, Fiorotto R, Cadamuro M, Fabris L, Strazzabosco M (2021) New insights on the role of vascular endothelial growth factor in biliary pathophysiology. JHEP Rep 3:100251. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100251","journal-title":"JHEP Rep"},{"key":"1545_CR85","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1038\/sj.emboj.7600709","volume":"24","author":"T Matsumoto","year":"2005","unstructured":"Matsumoto T, Bohman S, Dixelius J, Berge T, Dimberg A, Magnusson P, Wang L, Wikner C, Qi JH, Wernstedt C, Wu J, Bruheim S, Mugishima H, Mukhopadhyay D, Spurkland A, Claesson-Welsh L (2005) VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J 24:2342\u20132353. https:\/\/doi.org\/10.1038\/sj.emboj.7600709","journal-title":"EMBO J"},{"key":"1545_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.cophys.2023.100691","author":"IR Mccracken","year":"2023","unstructured":"Mccracken IR, Baker AH, Smart N, De Val S (2023) Transcriptional regulators of arterial and venous identity in the developing mammalian embryo. Curr Opin Physiol. https:\/\/doi.org\/10.1016\/j.cophys.2023.100691","journal-title":"Curr Opin Physiol"},{"key":"1545_CR87","doi-asserted-by":"publisher","first-page":"18281","DOI":"10.1073\/pnas.1207759109","volume":"109","author":"M Mctigue","year":"2012","unstructured":"Mctigue M, Murray BW, Chen JH, Deng YL, Solowiej J, Kania RS (2012) Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors. Proc Natl Acad Sci U S A 109:18281\u201318289. https:\/\/doi.org\/10.1073\/pnas.1207759109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1545_CR88","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1016\/j.cub.2019.07.035","volume":"29","author":"A Mehidi","year":"2019","unstructured":"Mehidi A, Rossier O, Schaks M, Chazeau A, Biname F, Remorino A, Coppey M, Karatas Z, Sibarita JB, Rottner K, Moreau V, Giannone G (2019) Transient activations of Rac1 at the lamellipodium tip trigger membrane protrusion. Curr Biol 29:2852-2866e5. https:\/\/doi.org\/10.1016\/j.cub.2019.07.035","journal-title":"Curr Biol"},{"key":"1545_CR89","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1080\/07391102.2021.1872417","volume":"40","author":"SJ Modi","year":"2022","unstructured":"Modi SJ, Kulkarni VM (2022) Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: Binding site analysis of type II, \u201cDFG-out\u201d inhibitors. J Biomol Struct Dyn 40:5712\u20135727. https:\/\/doi.org\/10.1080\/07391102.2021.1872417","journal-title":"J Biomol Struct Dyn"},{"key":"1545_CR90","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3389\/fcell.2020.00584","volume":"8","author":"C Montemagno","year":"2020","unstructured":"Montemagno C, Pages G (2020) Resistance to anti-angiogenic therapies: a mechanism depending on the time of exposure to the drugs. Front Cell Dev Biol 8:584. https:\/\/doi.org\/10.3389\/fcell.2020.00584","journal-title":"Front Cell Dev Biol"},{"key":"1545_CR91","doi-asserted-by":"publisher","first-page":"1234104","DOI":"10.3389\/fphys.2023.1234104","volume":"14","author":"W Nan","year":"2023","unstructured":"Nan W, He Y, Wang S, Zhang Y (2023) Molecular mechanism of VE-cadherin in regulating endothelial cell behaviour during angiogenesis. Front Physiol 14:1234104. https:\/\/doi.org\/10.3389\/fphys.2023.1234104","journal-title":"Front Physiol"},{"key":"1545_CR92","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.102440","author":"S Nornes","year":"2025","unstructured":"Nornes S, Bruche S, Adak N, Mccracken IR, De Val S (2025) Evaluating the transcriptional regulators of arterial gene expression via a catalogue of characterized arterial enhancers. Elife. https:\/\/doi.org\/10.7554\/eLife.102440","journal-title":"Elife"},{"key":"1545_CR93","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1158\/0008-5472.CAN-14-","volume":"76","author":"RK O\u2019donnell","year":"2016","unstructured":"O\u2019donnell RK, Falcon B, Hanson J, Goldstein WE, Perruzzi C, Rafii S, Aird WC, Benjamin LE (2016) VEGF-A\/VEGFR inhibition restores hematopoietic homeostasis in the bone marrow and attenuates tumor growth. Cancer Res 76:517\u201324. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-","journal-title":"Cancer Res"},{"key":"1545_CR94","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1177\/1758834011422556","volume":"3","author":"SL Organ","year":"2011","unstructured":"Organ SL, Tsao MS (2011) An overview of the c-MET signaling pathway. Ther Adv Med Oncol 3:S7\u2013S19. https:\/\/doi.org\/10.1177\/1758834011422556","journal-title":"Ther Adv Med Oncol"},{"key":"1545_CR95","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10456-024-09968-y","volume":"28","author":"S Pal","year":"2025","unstructured":"Pal S, Su Y, Nwadozi E, Claesson-Welsh L, Richards M (2025) Correction: neuropilin-1 controls vascular permeability through juxtacrine regulation of endothelial adherens junctions. Angiogenesis 28:16. https:\/\/doi.org\/10.1007\/s10456-024-09968-y","journal-title":"Angiogenesis"},{"key":"1545_CR96","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1","volume":"41","author":"EM Paleolog","year":"1998","unstructured":"Paleolog EM, Young S, Stark AC, Mccloskey RV, Feldmann M, Maini RN (1998) Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 41:1258\u20131265. https:\/\/doi.org\/10.1002\/1529-0131(199807)41:7%3c1258::AID-ART17%3e3.0.CO;2-1","journal-title":"Arthritis Rheum"},{"key":"1545_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/biom9080355","author":"A Paradowska-Gorycka","year":"2019","unstructured":"Paradowska-Gorycka A, Stypinska B, Pawlik A, Malinowski D, Romanowska-Prochnicka K, Manczak M, Olesinska M (2019) KDR (VEGFR2) genetic variants and serum levels in patients with rheumatoid arthritis. Biomolecules. https:\/\/doi.org\/10.3390\/biom9080355","journal-title":"Biomolecules"},{"key":"1545_CR98","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5483\/bmbrep.2018.51.2.233","volume":"51","author":"SA Park","year":"2018","unstructured":"Park SA, Jeong MS, Ha KT, Jang SB (2018) Structure and function of vascular endothelial growth factor and its receptor system. BMB Rep 51:73\u201378. https:\/\/doi.org\/10.5483\/bmbrep.2018.51.2.233","journal-title":"BMB Rep"},{"key":"1545_CR99","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1126\/science.aal3622","volume":"359","author":"ER Pereira","year":"2018","unstructured":"Pereira ER, Kedrin D, Seano G, Gautier O, Meijer EFJ, Jones D, Chin SM, Kitahara S, Bouta EM, Chang J, Beech E, Jeong HS, Carroll MC, Taghian AG, Padera TP (2018) Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 359:1403\u20131407. https:\/\/doi.org\/10.1126\/science.aal3622","journal-title":"Science"},{"key":"1545_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22042179","author":"S Rezzola","year":"2021","unstructured":"Rezzola S, Guerra J, Krishna Chandran AM, Loda A, Cancarini A, Sacristani P, Semeraro F, Presta M (2021) VEGF-independent activation of muller cells by the vitreous from proliferative diabetic retinopathy patients. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22042179","journal-title":"Int J Mol Sci"},{"key":"1545_CR101","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12974-014-0227-y","volume":"12","author":"B Rodriguez-Grande","year":"2015","unstructured":"Rodriguez-Grande B, Varghese L, Molina-Holgado F, Rajkovic O, Garlanda C, Denes A, Pinteaux E (2015) Pentraxin 3 mediates neurogenesis and angiogenesis after cerebral ischaemia. J Neuroinflammation 12:15. https:\/\/doi.org\/10.1186\/s12974-014-0227-y","journal-title":"J Neuroinflammation"},{"key":"1545_CR102","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1096\/fj.02-0134fje","volume":"16","author":"P Salven","year":"2002","unstructured":"Salven P, Hattori K, Heissig B, Rafii S (2002) Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J 16:1471\u20131473. https:\/\/doi.org\/10.1096\/fj.02-0134fje","journal-title":"FASEB J"},{"key":"1545_CR103","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.13876","volume":"5","author":"S Sarabipour","year":"2016","unstructured":"Sarabipour S, Ballmer-Hofer K, Hristova K (2016) VEGFR-2 conformational switch in response to ligand binding. Elife 5:e13876. https:\/\/doi.org\/10.7554\/eLife.13876","journal-title":"Elife"},{"key":"1545_CR104","doi-asserted-by":"publisher","first-page":"CD011346","DOI":"10.1002\/14651858.CD011346.pub2","volume":"2","author":"S Sarwar","year":"2016","unstructured":"Sarwar S, Clearfield E, Soliman MK, Sadiq MA, Baldwin AJ, Hanout M, Agarwal A, Sepah YJ, Do DV, Nguyen QD (2016) Aflibercept for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2:CD011346. https:\/\/doi.org\/10.1002\/14651858.CD011346.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1545_CR105","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1242\/jcs.049908","volume":"122","author":"H Sase","year":"2009","unstructured":"Sase H, Watabe T, Kawasaki K, Miyazono K, Miyazawa K (2009) VEGFR2-PLCgamma1 axis is essential for endothelial specification of VEGFR2+ vascular progenitor cells. J Cell Sci 122:3303\u20133311. https:\/\/doi.org\/10.1242\/jcs.049908","journal-title":"J Cell Sci"},{"key":"1545_CR106","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1042\/BJ20020137","volume":"368","author":"D Senthil","year":"2002","unstructured":"Senthil D, Ghosh Choudhury G, Bhandari BK, Kasinath BS (2002) The type 2 vascular endothelial growth factor receptor recruits insulin receptor substrate-1 in its signalling pathway. Biochem J 368:49\u201356. https:\/\/doi.org\/10.1042\/BJ20020137","journal-title":"Biochem J"},{"key":"1545_CR107","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cytogfr.2024.07.005","volume":"78","author":"FH Shah","year":"2024","unstructured":"Shah FH, Lee HW (2024) Endothelial and macrophage interactions in the angiogenic niche. Cytokine Growth Factor Rev 78:64\u201376. https:\/\/doi.org\/10.1016\/j.cytogfr.2024.07.005","journal-title":"Cytokine Growth Factor Rev"},{"key":"1545_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/biom10121673","author":"F Shaik","year":"2020","unstructured":"Shaik F, Cuthbert GA, Homer-Vanniasinkam S, Muench SP, Ponnambalam S, Harrison MA (2020) Structural basis for vascular endothelial growth factor receptor activation and implications for disease therapy. Biomolecules. https:\/\/doi.org\/10.3390\/biom10121673","journal-title":"Biomolecules"},{"key":"1545_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/cells11193108","author":"K Sharma","year":"2022","unstructured":"Sharma K, Zhang Y, Paudel KR, Kachelmeier A, Hansbro PM, Shi X (2022) The emerging role of pericyte-derived extracellular vesicles in vascular and neurological health. Cells. https:\/\/doi.org\/10.3390\/cells11193108","journal-title":"Cells"},{"key":"1545_CR110","doi-asserted-by":"publisher","first-page":"29979","DOI":"10.1074\/jbc.273.45.29979","volume":"273","author":"BQ Shen","year":"1998","unstructured":"Shen BQ, Lee DY, Gerber HP, Keyt BA, Ferrara N, Zioncheck TF (1998) Homologous up-regulation of KDR\/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem 273:29979\u201329985. https:\/\/doi.org\/10.1074\/jbc.273.45.29979","journal-title":"J Biol Chem"},{"key":"1545_CR111","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jconrel.2022.07.015","volume":"349","author":"R Shen","year":"2022","unstructured":"Shen R, Peng L, Zhou W, Wang D, Jiang Q, Ji J, Hu F, Yuan H (2022) Anti-angiogenic nano-delivery system promotes tumor vascular normalizing and micro-environment reprogramming in solid tumor. J Control Release 349:550\u2013564. https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.015","journal-title":"J Control Release"},{"key":"1545_CR112","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/hep.30889","volume":"71","author":"K Shigeta","year":"2020","unstructured":"Shigeta K, Datta M, Hato T, Kitahara S, Chen IX, Matsui A, Kikuchi H, Mamessier E, Aoki S, Ramjiawan RR, Ochiai H, Bardeesy N, Huang P, Cobbold M, Zhu AX, Jain RK, Duda DG (2020) Dual programmed death receptor-1 and vascular endothelial growth factor receptor-2 blockade promotes vascular normalization and enhances antitumor immune responses in hepatocellular carcinoma. Hepatology 71:1247\u20131261. https:\/\/doi.org\/10.1002\/hep.30889","journal-title":"Hepatology"},{"key":"1545_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010275","author":"JW Shim","year":"2018","unstructured":"Shim JW, Madsen JR (2018) VEGF signaling in neurological disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19010275","journal-title":"Int J Mol Sci"},{"key":"1545_CR114","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s10637-011-9683-8","volume":"30","author":"SJ Shin","year":"2012","unstructured":"Shin SJ, Jung M, Jeung HC, Kim HR, Rha SY, Roh JK, Chung HC, Ahn JB (2012) A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy. Invest New Drugs 30:1501\u20131510. https:\/\/doi.org\/10.1007\/s10637-011-9683-8","journal-title":"Invest New Drugs"},{"key":"1545_CR115","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nbt1323","volume":"25","author":"F Shojaei","year":"2007","unstructured":"Shojaei F, Wu X, Malik AK, Zhong C, Baldwin ME, Schanz S, Fuh G, Gerber HP, Ferrara N (2007) Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nat Biotechnol 25:911\u2013920. https:\/\/doi.org\/10.1038\/nbt1323","journal-title":"Nat Biotechnol"},{"key":"1545_CR116","doi-asserted-by":"publisher","first-page":"7758","DOI":"10.1128\/MCB.22.22.7758-7768.2002","volume":"22","author":"X Shu","year":"2002","unstructured":"Shu X, Wu W, Mosteller RD, Broek D (2002) Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol Cell Biol 22:7758\u20137768. https:\/\/doi.org\/10.1128\/MCB.22.22.7758-7768.2002","journal-title":"Mol Cell Biol"},{"key":"1545_CR117","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161366","author":"E Sjoberg","year":"2023","unstructured":"Sjoberg E, Melssen M, Richards M, Ding Y, Chanoca C, Chen D, Nwadozi E, Pal S, Love DT, Ninchoji T, Shibuya M, Simons M, Dimberg A, Claesson-Welsh L (2023) Endothelial VEGFR2-PLCgamma signaling regulates vascular permeability and antitumor immunity through eNOS\/Src. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI161366","journal-title":"J Clin Invest"},{"key":"1545_CR118","doi-asserted-by":"publisher","first-page":"7019","DOI":"10.1021\/bi900522y","volume":"48","author":"J Solowiej","year":"2009","unstructured":"Solowiej J, Bergqvist S, Mctigue MA, Marrone T, Quenzer T, Cobbs M, Ryan K, Kania RS, Diehl W, Murray BW (2009) Characterizing the effects of the juxtamembrane domain on vascular endothelial growth factor receptor-2 enzymatic activity, autophosphorylation, and inhibition by axitinib. Biochemistry 48:7019\u20137031. https:\/\/doi.org\/10.1021\/bi900522y","journal-title":"Biochemistry"},{"key":"1545_CR119","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1084\/jem.20111343","volume":"209","author":"Z Sun","year":"2012","unstructured":"Sun Z, Li X, Massena S, Kutschera S, Padhan N, Gualandi L, Sundvold-Gjerstad V, Gustafsson K, Choy WW, Zang G, Quach M, Jansson L, Phillipson M, Abid MR, Spurkland A, Claesson-Welsh L (2012) VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J Exp Med 209:1363\u20131377. https:\/\/doi.org\/10.1084\/jem.20111343","journal-title":"J Exp Med"},{"key":"1545_CR120","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/iub.1358","volume":"67","author":"A Szade","year":"2015","unstructured":"Szade A, Grochot-Przeczek A, Florczyk U, Jozkowicz A, Dulak J (2015) Cellular and molecular mechanisms of inflammation-induced angiogenesis. IUBMB Life 67:145\u2013159. https:\/\/doi.org\/10.1002\/iub.1358","journal-title":"IUBMB Life"},{"key":"1545_CR121","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/sj.onc.1201047","volume":"14","author":"T Takahashi","year":"1997","unstructured":"Takahashi T, Shibuya M (1997) The 230 kDa mature form of KDR\/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene 14:2079\u20132089. https:\/\/doi.org\/10.1038\/sj.onc.1201047","journal-title":"Oncogene"},{"key":"1545_CR122","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1038\/sj.onc.1202527","volume":"18","author":"T Takahashi","year":"1999","unstructured":"Takahashi T, Ueno H, Shibuya M (1999) VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18:2221\u20132230. https:\/\/doi.org\/10.1038\/sj.onc.1202527","journal-title":"Oncogene"},{"key":"1545_CR123","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/emboj\/20.11.2768","volume":"20","author":"T Takahashi","year":"2001","unstructured":"Takahashi T, Yamaguchi S, Chida K, Shibuya M (2001) A single autophosphorylation site on KDR\/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 20:2768\u20132778. https:\/\/doi.org\/10.1093\/emboj\/20.11.2768","journal-title":"EMBO J"},{"key":"1545_CR124","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1111\/cas.14942","volume":"112","author":"T Tomita","year":"2021","unstructured":"Tomita T, Kato M, Hiratsuka S (2021) Regulation of vascular permeability in cancer metastasis. Cancer Sci 112:2966\u20132974. https:\/\/doi.org\/10.1111\/cas.14942","journal-title":"Cancer Sci"},{"key":"1545_CR125","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1242\/jcs.178434","volume":"129","author":"K Tsuji-Tamura","year":"2016","unstructured":"Tsuji-Tamura K, Ogawa M (2016) Inhibition of the PI3K-Akt and mTORC1 signaling pathways promotes the elongation of vascular endothelial cells. J Cell Sci 129:1165\u20131178. https:\/\/doi.org\/10.1242\/jcs.178434","journal-title":"J Cell Sci"},{"key":"1545_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110849","volume":"110","author":"K Tyagi","year":"2023","unstructured":"Tyagi K, Roy A, Mandal S (2023) Pharmacological inhibition of protein kinase D suppresses epithelial ovarian cancer via MAPK\/ERK1\/2\/Runx2 signalling axis. Cell Signal 110:110849. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110849","journal-title":"Cell Signal"},{"key":"1545_CR127","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1038\/s41467-021-24367-3","volume":"12","author":"E Uchikawa","year":"2021","unstructured":"Uchikawa E, Chen Z, Xiao GY, Zhang X, Bai XC (2021) Structural basis of the activation of c-MET receptor. Nat Commun 12:4074. https:\/\/doi.org\/10.1038\/s41467-021-24367-3","journal-title":"Nat Commun"},{"key":"1545_CR128","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jmb.2007.01.036","volume":"367","author":"M Walter","year":"2007","unstructured":"Walter M, Lucet IS, Patel O, Broughton SE, Bamert R, Williams NK, Fantino E, Wilks AF, Rossjohn J (2007) The 2.7 A crystal structure of the autoinhibited human c-Fms kinase domain. J Mol Biol 367:839\u201347. https:\/\/doi.org\/10.1016\/j.jmb.2007.01.036","journal-title":"J Mol Biol"},{"key":"1545_CR129","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1073\/pnas.0802857105","volume":"105","author":"S Wang","year":"2008","unstructured":"Wang S, Li X, Parra M, Verdin E, Bassel-Duby R, Olson EN (2008) Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. Proc Natl Acad Sci U S A 105:7738\u20137743. https:\/\/doi.org\/10.1073\/pnas.0802857105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1545_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.599281","volume":"8","author":"X Wang","year":"2020","unstructured":"Wang X, Bove AM, Simone G, Ma B (2020) Molecular bases of VEGFR-2-mediated physiological function and pathological role. Front Cell Dev Biol 8:599281. https:\/\/doi.org\/10.3389\/fcell.2020.599281","journal-title":"Front Cell Dev Biol"},{"key":"1545_CR500","doi-asserted-by":"crossref","unstructured":"Wang L, Liu WQ, Broussy S, Han B, Fang H (2023) Recent advances of anti-angiogenic inhibitors targeting VEGF\/VEGFR axis. Front Pharmacol 14:1307860. https:\/\/doi.org\/10.3389\/fphar.2023.1307860","DOI":"10.3389\/fphar.2023.1307860"},{"key":"1545_CR131","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1007\/s10528-023-10547-x","volume":"62","author":"M Wang","year":"2024","unstructured":"Wang M, Wang X, Zhang Y, Gu J, Zhang J, Wen X (2024a) Transcription factor FOSL1 promotes angiogenesis of colon carcinoma by regulating the VEGF PATHWAY through activating TIMP1. Biochem Genet 62:3389\u20133402. https:\/\/doi.org\/10.1007\/s10528-023-10547-x","journal-title":"Biochem Genet"},{"key":"1545_CR132","doi-asserted-by":"publisher","first-page":"L503","DOI":"10.1152\/ajplung.00077.202","volume":"327","author":"S Wang","year":"2024","unstructured":"Wang S, Awad KS, Chen LY, Siddique MAH, Ferreyra GA, Wang CL, Joseph T, Yu ZX, Takeda K, Demirkale CY, Zhao YY, Elinoff JM, Danner RL (2024) Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2alpha. Am J Physiol Lung Cell Mol Physiol 327:L503\u2013L519. https:\/\/doi.org\/10.1152\/ajplung.00077.202","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1545_CR133","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1042\/0264-6021:3470501","volume":"347","author":"AJ Warner","year":"2000","unstructured":"Warner AJ, Lopez-Dee J, Knight EL, Feramisco JR, Prigent SA (2000) The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells. Biochem J 347:501\u2013509. https:\/\/doi.org\/10.1042\/0264-6021:3470501","journal-title":"Biochem J"},{"key":"1545_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41540-017-0037-9","volume":"4","author":"JC Weddell","year":"2018","unstructured":"Weddell JC, Chen S, Imoukhuede PI (2018) VEGFR1 promotes cell migration and proliferation through PLCgamma and PI3K pathways. NPJ Syst Biol Appl 4:1. https:\/\/doi.org\/10.1038\/s41540-017-0037-9","journal-title":"NPJ Syst Biol Appl"},{"key":"1545_CR135","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1182\/blood-2009-03-211391","volume":"114","author":"G Wei","year":"2009","unstructured":"Wei G, Srinivasan R, Cantemir-Stone CZ, Sharma SM, Santhanam R, Weinstein M, Muthusamy N, Man AK, Oshima RG, Leone G, Ostrowski MC (2009) Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. Blood 114:1123\u20131130. https:\/\/doi.org\/10.1182\/blood-2009-03-211391","journal-title":"Blood"},{"key":"1545_CR136","doi-asserted-by":"publisher","first-page":"33262","DOI":"10.1074\/jbc.M503198200","volume":"280","author":"C Wong","year":"2005","unstructured":"Wong C, Jin ZG (2005) Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor. J Biol Chem 280:33262\u201333269. https:\/\/doi.org\/10.1074\/jbc.M503198200","journal-title":"J Biol Chem"},{"key":"1545_CR137","doi-asserted-by":"publisher","first-page":"960327123117164","DOI":"10.1177\/09603271231171642","volume":"42","author":"X Yang","year":"2023","unstructured":"Yang X, Li D (2023) Tricin attenuates diabetic retinopathy by inhibiting oxidative stress and angiogenesis through regulating Sestrin2\/Nrf2 signaling. Hum Exp Toxicol 42:9603271231171642. https:\/\/doi.org\/10.1177\/09603271231171642","journal-title":"Hum Exp Toxicol"},{"key":"1545_CR138","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1073\/pnas.0914052107","volume":"107","author":"Y Yang","year":"2010","unstructured":"Yang Y, Xie P, Opatowsky Y, Schlessinger J (2010) Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling. Proc Natl Acad Sci U S A 107:1906\u20131911. https:\/\/doi.org\/10.1073\/pnas.0914052107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1545_CR139","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1126\/science.1068327","volume":"295","author":"JL Yu","year":"2002","unstructured":"Yu JL, Rak JW, Coomber BL, Hicklin DJ, Kerbel RS (2002) Effect of p53 status on tumor response to antiangiogenic therapy. Science 295:1526\u20131528. https:\/\/doi.org\/10.1126\/science.1068327","journal-title":"Science"},{"key":"1545_CR140","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12645-023-00213-7","volume":"14","author":"F Zahedipour","year":"2023","unstructured":"Zahedipour F, Zamani P, Mashreghi M, Astaneh M, Sankian M, Amiri A, Jamialahmadi K, Jaafari MR (2023) Nanoliposomal VEGF-R2 peptide vaccine acts as an effective therapeutic vaccine in a murine B16F10 model of melanoma. Cancer Nanotechnol 14:62. https:\/\/doi.org\/10.1186\/s12645-023-00213-7","journal-title":"Cancer Nanotechnol"},{"key":"1545_CR141","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mvr.2011.06.007","volume":"83","author":"N Zebda","year":"2012","unstructured":"Zebda N, Dubrovskyi O, Birukov KG (2012) Focal adhesion kinase regulation of mechanotransduction and its impact on endothelial cell functions. Microvasc Res 83:71\u201381. https:\/\/doi.org\/10.1016\/j.mvr.2011.06.007","journal-title":"Microvasc Res"},{"key":"1545_CR142","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1159\/000373978","volume":"35","author":"Z Zhang","year":"2015","unstructured":"Zhang Z, Zhang T, Zhou Y, Wei X, Zhu J, Zhang J, Wang C (2015) Activated phosphatidylinositol 3-kinase\/Akt inhibits the transition of endothelial progenitor cells to mesenchymal cells by regulating the forkhead box subgroup O-3a signaling. Cell Physiol Biochem 35:1643\u20131653. https:\/\/doi.org\/10.1159\/000373978","journal-title":"Cell Physiol Biochem"},{"key":"1545_CR143","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1074\/jbc.M116.766832","volume":"292","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Li Q, Youn JY, Cai H (2017) Protein phosphotyrosine phosphatase 1B (PTP1B) in calpain-dependent feedback regulation of vascular endothelial growth factor receptor (VEGFR2) in endothelial cells: implications In VEGF-dependent angiogenesis and diabetic wound healing. J Biol Chem 292:407\u2013416. https:\/\/doi.org\/10.1074\/jbc.M116.766832","journal-title":"J Biol Chem"},{"key":"1545_CR600","doi-asserted-by":"publisher","unstructured":"Zhang AB, Mozaffari K, Aguirre B, Li V, Kubba R, Desai NC, Wei D, Yang I, Wadehra M (2023) Exploring the\npast, present, and future of anti-angiogenic therapy in Glioblastoma. Cancers (Basel) 15:830. https:\/\/doi.org\/10.3390\/cancers15030830","DOI":"10.3390\/cancers15030830"},{"key":"1545_CR144","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.7150\/ijbs.70958","volume":"18","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Guo S, Deng J, Shen J, Du F, Wu X, Chen Y, Li M, Chen M, Li X, Li W, Gu L, Sun Y, Wen Q, Li J, Xiao Z (2022) VEGF\/VEGFR-targeted therapy and immunotherapy in non-small cell lung cancer: targeting the tumor microenvironment. Int J Biol Sci 18:3845\u20133858. https:\/\/doi.org\/10.7150\/ijbs.70958","journal-title":"Int J Biol Sci"},{"key":"1545_CR145","doi-asserted-by":"publisher","first-page":"390","DOI":"10.31083\/j.fbl2911390","volume":"29","author":"C Zhao","year":"2024","unstructured":"Zhao C, Miao D, Tan D, Shi J, Lv Q, Xiong Z, Zhang X (2024) The PLCG2 inhibits tumor progression and mediates angiogenesis by VEGF signaling pathway in clear cell renal cell carcinoma. Front Biosci 29:390. https:\/\/doi.org\/10.31083\/j.fbl2911390","journal-title":"Front Biosci"},{"key":"1545_CR146","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1161\/CIRCULATIONAHA.122.061900","volume":"146","author":"W Zhou","year":"2022","unstructured":"Zhou W, Liu K, Zeng L, He J, Gao X, Gu X, Chen X, Jing Li J, Wang M, Wu D, Cai Z, Claesson-Welsh L, Ju R, Wang J, Zhang F, Chen Y (2022) Targeting VEGF-A\/VEGFR2 Y949 signaling-mediated vascular permeability alleviates hypoxic pulmonary hypertension. Circulation 146:1855\u20131881. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.061900","journal-title":"Circulation"},{"key":"1545_CR147","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1158\/0008-5472.CAN-09-1845","volume":"70","author":"G Zhuang","year":"2010","unstructured":"Zhuang G, Brantley-Sieders DM, Vaught D, Yu J, Xie L, Wells S, Jackson D, Muraoka-Cook R, Arteaga C, Chen J (2010) Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy. Cancer Res 70:299\u2013308. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1845","journal-title":"Cancer Res"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-025-01545-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-025-01545-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-025-01545-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T12:09:33Z","timestamp":1748261373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-025-01545-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":149,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1545"],"URL":"https:\/\/doi.org\/10.1007\/s12272-025-01545-1","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}